Cosmetics

UK Chemical Supply Chain Faces Plateauing Growth and Persistent Challenges

mmyworldfix
mmyworldfixFeb 17, 2025

The latest quarterly survey by the Chemical Business Association (CBA) reveals that while the UK chemical supply chain remains robust, growth appears to be stagnating. Key findings include a decline in order books, sales, and employment expectations. Despite some improvements in logistics disruptions, ongoing challenges such as rising road haulage costs and regulatory issues continue to impact the industry. The CBA emphasizes the need for urgent policy intervention to address these concerns and ensure the UK's competitiveness.

Stagnant Sales and Margins Highlight Industry Concerns

The survey highlights a concerning trend of stagnant sales and margins within the UK chemical supply chain. A significant portion of respondents reported no change in their order books, with only a small fraction noting improvements. This trend is reflected in both current and projected sales figures, indicating a potential slowdown in growth. Additionally, future margin expectations show signs of decline, with more companies anticipating worsening conditions.

In detail, the survey results reveal that 55% of respondents indicated that their order books remained unchanged, while just 18% saw improvements. Only 20% reported better sales over the past three months, marking a 15% downturn from the same period in 2023. Looking ahead, only 19% expect an improvement in sales for the first quarter of 2025, down from 34% in Q4 2023. Furthermore, 69% of respondents noted no change in sales margins, while 32% anticipate worse conditions in the coming months. These findings underscore the growing concern about the industry's ability to sustain growth amidst economic uncertainties.

Logistical Improvements Amidst Ongoing Challenges

While the survey points to some logistical improvements, persistent challenges remain. Fewer companies are experiencing disruptions related to the Red Sea and Suez Canal, and road haulage capacity issues have decreased significantly. However, escalating road haulage costs and regulatory hurdles, particularly those linked to Brexit, continue to pose obstacles. The CBA stresses the importance of addressing these issues to enhance the sector's resilience and competitiveness.

Specifically, the survey shows that 48% of respondents still face disruptions due to the Red Sea and Suez Canal, a notable reduction from 70% in Q4 2023. Similarly, only 3% reported ongoing road haulage capacity issues, compared to 22% in the final quarter of 2023. Despite these improvements, members highlighted ongoing challenges such as rising road haulage costs and unresolved regulatory issues, especially concerning UK REACH. Since December 2021, when DEFRA announced plans to explore a new model, meaningful progress has been lacking, leading to uncertainty and hindered trade and investment. The CBA remains committed to working with the government to find practical solutions that drive growth and resilience, ensuring the UK chemical supply chain remains competitive on the global stage.

Related Articles

Unveiling Sally Beauty's Strategic Shift: A Path to Profitability Amidst Sales Stagnation
Cosmetics

Unveiling Sally Beauty's Strategic Shift: A Path to Profitability Amidst Sales Stagnation

Sally Beauty reported flat year-on-year quarterly sales of US$937.9 million, meeting analyst estimates but offering lower-than-expected guidance for the next quarter. Despite modest top-line performance, the stock surged due to anticipated operational improvements. Revenue remained steady at US$937.9 million, with non-GAAP EPS at US$0.43 per share. However, Q1 CY2025 revenue guidance is 2.3% below projections. Operating margin improved to 10.7% from 7.4%, and free cash flow margin rose to 6.1% from 2.2%. Sally Beauty operated 4,453 stores, with a 1.6% increase in same-store sales. The company aims to enhance profitability by closing underperforming stores and focusing on high-performing locations, positioning itself better in a competitive market dominated by larger retailers. Analysts project a modest 1.1% revenue growth for the coming year.

mmyworldfixFeb 17, 2025
Hugel Achieves Record-Breaking Performance in 2024, Eyeing Global Expansion
Cosmetics

Hugel Achieves Record-Breaking Performance in 2024, Eyeing Global Expansion

Hugel, a South Korea-based company, reported its strongest annual performance in 2024, with net sales of KRW373.0 billion, operating profit of KRW166.3 billion, and net income of KRW142.4 billion, marking year-over-year increases of 16.7%, 41.2%, and 45.8%, respectively. The success was driven by Letybo (botulinum toxin) generating KRW203.2 billion in sales, bolstered by the Asia-Pacific market and US shipments. Revolax (HA fillers) contributed KRW127.6 billion, with strong sales in China and growth in Europe and MENA. WELLAGE and BYRYZN BR cosmetics saw a 37.8% increase to KRW36.9 billion. For 2025, Hugel aims for a 10% US market share and 30% in key MENA markets, leveraging strong consumer demand for medical aesthetics and premium skincare, especially in emerging regions like the Middle East.

mmyworldfixFeb 17, 2025
Hydrinity Expands to UK and Ireland Through Strategic Partnership
Cosmetics

Hydrinity Expands to UK and Ireland Through Strategic Partnership

Hydrinity Accelerated Skin Science is expanding into the UK and Ireland via a partnership with Unique Skin, a leading distributor in advanced aesthetics and skincare. This move targets a rapidly growing market projected to reach US$5 billion by 2025 and exceed US$8 billion by 2032, fueled by a 350% increase in cosmetic surgery and aesthetic clinics since 2010. Hydrinity’s clinically proven, minimalistic approach will be introduced to over 1,400 dermatologists, 740 plastic surgeons, and 4,600 clinics. The expansion leverages rising interest in medical-grade skincare and increasing disposable income, positioning Hydrinity to capitalize on the premium beauty market's growth.

mmyworldfixFeb 17, 2025